W STRATEGIES, LLC

Lobbying for ASTRAZENECA PHARMACEUTICALS LP · Biopharmaceutical Company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate · $80,000.00 income · posted Oct 20, 2025

Bills named in this filing 1

Lobbying activity 1

Medicare/Medicaid

Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.